Alkaloid Synthesis and Anticancer Activity

Alkaloids represent a diverse class of nitrogenous natural products renowned for their pronounced biological activities, and their incorporation into anticancer regimens has inspired extensive synthetic and mechanistic studies. Advances in stereoselective methodologies have facilitated the construction of complex polycyclic frameworks, including indolizidine and phenanthroindolizidine cores, often employing cascade cyclisations, chiral auxiliaries or metal-mediated annulations to control regio- and stereochemistry. Parallel efforts in total synthesis have unlocked access to rare plant-derived structures, enabling detailed structure–activity relationship investigations. On the biological front, these compounds exert anticancer effects via multiple pathways: inhibition of transcription factors, interference with signalling cascades such as PI3K/Akt and MAPK, disruption of cell-cycle progression, and blockade of angiogenesis. The modular nature of synthetic routes has also permitted the design of prodrugs and hypoxia-activated derivatives to enhance tumour selectivity and minimise off-target toxicity. Collectively, these developments underscore the global significance of alkaloid chemistry in generating new leads and tools for cancer therapy, bridging foundational synthetic innovation with in-depth mechanistic understanding.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Alkaloid Synthesis and Anticancer Activity publication trend

The graph below shows the total number of articles in alkaloid synthesis and anticancer activity across all publications each year (not limited to Nature Index journals).

Technical terms

Alkaloid: A naturally occurring nitrogen-containing compound with diverse biological activities.

Phenanthroindolizidine alkaloids: Polycyclic nitrogenous structures featuring a phenanthrene fused to an indolizidine ring.

Prodrug: An inactive precursor that undergoes biotransformation to release an active pharmaceutical agent.

Hypoxia: A condition of reduced oxygen availability typical of solid tumour microenvironments.

Nuclear factor kappa B (NFκB): A transcription factor regulating inflammation, cell survival and proliferation.

IκBα: An inhibitory protein that sequesters NFκB in the cytoplasm until degradation permits NFκB activation.

Spheroid: A three-dimensional cell culture model that closely mimics the architecture and gradients of solid tumours.

G0/G1 arrest: The halting of cell-cycle progression at the initial gap phase before DNA synthesis.

References

1. Phenanthroindolizidine Alkaloids Isolated from Tylophora ovata as Potent Inhibitors of Inflammation, Spheroid Growth, and Invasion of Triple-Negative Breast Cancer. International Journal of Molecular Sciences (2022).
2. Design, Synthesis and In-Vitro Biological Evaluation of Antofine and Tylophorine Prodrugs as Hypoxia-Targeted Anticancer Agents. Molecules (2021).